+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Hydroxychloroquine Global Market Report 2020-30: COVID-19 Implications and Growth

  • ID: 5125742
  • Report
  • July 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • Bayer AG
  • Concordia Healthcare
  • Intas Pharmaceuticals
  • Lupin Limited
  • Mylan
  • Shanghai Pharma
Hydroxychloroquine Global Market Report 2020-30: COVID-19 Implications and Growth provides the strategists, marketers and senior management with the critical information they need to assess the global hydroxychloroquine market.

This report focuses on hydroxychloroquine market which is experiencing strong growth. The report gives a guide to the hydroxychloroquine market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the hydroxychloroquine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hydroxychloroquine market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider hydroxychloroquine market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The hydroxychloroquine market section of the report gives context. It compares the hydroxychloroquine market with other segments of the hydroxychloroquine market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, hydroxychloroquine indicators comparison.
Scope

Markets Covered:
1) By Drug Activity: Anti-Malarial; Anti-Rheumatic; Lupus Suppressant; Anti COVID19; Others
2) By Formulation: Tablets; Injection
3) By Application: Malaria; Rheumatoid arthritis; Lupus Erythematosus; COVID-19; Others
4) By Distribution Channel: Hospital pharmacy; Online pharmacy; Specialty drug stores; Retail pharmacy

Companies Mentioned: Bayer AG; Dr. Reddy's Laboratories; Zydus Cadila; Ipca Laboratories Ltd.; Wallace Pharma

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Concordia Healthcare
  • Intas Pharmaceuticals
  • Lupin Limited
  • Mylan
  • Shanghai Pharma
1. Executive Summary

2. Hydroxychloroquine Market Characteristics

3. Hydroxychloroquine Market Size and Growth
3.1. Global Hydroxychloroquine Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers of the Market
3.1.2. Restraints on the Market
3.2. Global Hydroxychloroquine Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers of the Market
3.2.2. Restraints on the Market

4. Hydroxychloroquine Market Segmentation
4.1. Global Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Anti-Malarial Drug
  • Anti-Rheumatic Drug
  • Lupus Suppressant Drug
  • Anti COVID19 Drug
  • Others
4.2. Global Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Tablets
  • Injection
4.3. Global Hydroxychloroquine Market, Segmentation by Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Malaria
  • Rheumatoid arthritis
  • Lupus Erythematosus
  • COVID-19
  • Others
4.4. Global Hydroxychloroquine Market, Segmentation by Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital pharmacy
  • Online pharmacy
  • Specialty drug stores
  • Retail pharmacy
5. Hydroxychloroquine Market Regional and Country Analysis
5.1. Global Hydroxychloroquine Market, Split by Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Hydroxychloroquine Market, Split by Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Hydroxychloroquine Market
6.1. Asia-Pacific Hydroxychloroquine Market Overview
6.2. Asia-Pacific Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Hydroxychloroquine Market
7.1. China Hydroxychloroquine Market Overview
7.2. China Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Hydroxychloroquine Market
8.1. India Hydroxychloroquine Market Overview
8.2. India Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Hydroxychloroquine Market
9.1. Japan Hydroxychloroquine Market Overview
9.2. Japan Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Hydroxychloroquine Market
10.1. Australia Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Hydroxychloroquine Market
11.1. Indonesia Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Hydroxychloroquine Market
12.1. South Korea Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Hydroxychloroquine Market
13.1. Western Europe Hydroxychloroquine Market Overview
13.2. Western Europe Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Hydroxychloroquine Market
14.1. UK Hydroxychloroquine Market Overview
14.2. UK Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Hydroxychloroquine Market
15.1. Germany Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Hydroxychloroquine Market
16.1. France Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.2. France Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Hydroxychloroquine Market
17.1. Eastern Europe Hydroxychloroquine Market Overview
17.2. Eastern Europe Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Hydroxychloroquine Market
18.1. Russia Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Hydroxychloroquine Market
19.1. North America Hydroxychloroquine Market Overview
19.2. North America Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Hydroxychloroquine Market
20.1. USA Hydroxychloroquine Market Overview
20.2. USA Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Hydroxychloroquine Market
21.1. South America Hydroxychloroquine Market Overview
21.2. South America Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Hydroxychloroquine Market
22.1. Brazil Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Hydroxychloroquine Market
23.1. Middle East Hydroxychloroquine Market Overview
23.2. Middle East Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Hydroxychloroquine Market
24.1. Africa Hydroxychloroquine Market Overview
24.2. Africa Hydroxychloroquine Market, Segmentation by Drug Activity, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Hydroxychloroquine Market, Segmentation by Formulation, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Hydroxychloroquine Market Competitive Landscape and Company Profiles
25.1. Hydroxychloroquine Market Competitive Landscape
25.2. Hydroxychloroquine Market Company Profiles
25.2.1. Bayer AG
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Dr. Reddy's Laboratories
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Zydus Cadila
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Ipca Laboratories Ltd.
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Wallace Pharma
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers and Acquisitions in the Hydroxychloroquine Market

27. Hydroxychloroquine Market Trends and Strategies

28. Hydroxychloroquine Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright and Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Bayer AG
  • Concordia Healthcare
  • Intas Pharmaceuticals
  • Lupin Limited
  • Mylan
  • Shanghai Pharma
Major players in the hydroxychloroquine market are Bayer AG, Dr. Reddy's Laboratories, Zydus Cadila, Ipca Laboratories Ltd., Wallace Pharma, Teva, Mylan, Novartis, and Intas Pharmaceuticals.

The global hydroxychloroquine market is expected to grow from $718 million in 2019 to $980.1 million in 2020 at a compound annual growth rate (CAGR) of 36.5%. The growth is mainly attributed to the COVID-19 outbreak and the urgent need to treat the growing number of cases. With no effective therapeutics discovered so far, some of the existing drugs including hydroxychloroquine have been repurposed for COVID-19 infection treatment. Hydroxychloroquine is found to be effective against coronavirus in laboratory studies and in-vivo studies. The market is then expected to stabilize and reach $1,281.3 million in 2023 at a CAGR of 9.3%.

The hydroxychloroquine market consists of revenue generated by establishments through the sales of hydroxychloroquine drugs. It is an antimalarial drug used for the treatment of malaria, systemic lupus erythematosus (SLE), and rheumatoid arthritis. Hydroxychloroquine is used in combination with antibiotic azithromycin as a potential treatment for COVID-19.

North America is anticipated to be the largest region in the global hydroxychloroquine market by the end of 2020. The Asia Pacific is expected to be the fastest-growing region in the forecast period.

Major players operating in the market are undertaking various strategic initiatives such as increasing production capacity and the expansion of manufacturing plants to meet the augmented global demand. For instance, in April 2020, Zydus Cadila announced that the company has ramped up its production capacity by 10 times for the production of hydroxychloroquine post the COVID 19 outbreak. Moreover, other manufacturers including IPCA Laboratories increased their monthly hydroxychloroquine production capacity five to six times during May 2020. Thus, the ramp-up of production capacities by major companies is a major trend shaping the hydroxychloroquine market.

The hydroxychloroquine market covered in this report is segmented by drug activity into anti-malarial; anti-rheumatic; lupus suppressant; anti-COVID-19; others. It is also segmented by formulation into tablets; injection, by application into malaria; rheumatoid arthritis; lupus erythematosus; COVID-19; others and by distribution channel into hospital pharmacy; online pharmacy; specialty drug stores; retail pharmacy.

Side effects associated with the use of hydroxychloroquine drugs is predicted to limit the market growth. The side effects associated with the use of hydroxychloroquine for the treatment of COVID patients include serious and potentially life-threatening heart rhythm problems. In April 2020, the US Food and Drug Administration warned against the side-effects of hydroxychloroquine and issued a safety communication regarding the side-effects of using the drug for COVID 19 outside of the hospital settings or clinical trials. Moreover, the World Health Organization (WHO) had suspended the clinical trials of hydroxychloroquine over safety concerns on the 25th of May 2020. However, the trials have been resumed by WHO on the 3rd of June 2020 after reviewing safety concerns. Nonetheless, the potential side effects restrict the use of hydroxychloroquine outside the hospital and clinical settings, thereby hindering the growth of the hydroxychloroquine market going forward.

In July 2019, Mylan N.V. and Pfizer Inc. announced a definitive agreement to combine Mylan with Upjohn, off-patent branded and generic establishment medicines business of Pfizer for an undisclosed amount to creating a new global pharmaceutical company. The new company is expected to transform and accelerate both companies’ ability to serve patients and expand their capabilities across more than 165 markets. Mylan N.V. was founded in 1961 and is a global generic and specialty pharmaceuticals company.

The increasing number of coronavirus cases has increased the demand for hydroxychloroquine in 2020. The demand for hydroxychloroquine is growing attributing to its use in the treatment of COVID-19 patients and in the ongoing clinical trials. The US Food and Drug Administration has authorized emergency use of hydroxychloroquine for the treatment of COVID-19 patients in the hospital or enrolled by clinical trials. According to the World Health Organization (WHO), there were more than 10 million confirmed cases of COVID-19, including more than 500,000 deaths reported as of 3rd July 2020, globally. USA, Brazil, Russia, UK, India and Spain are the countries most affected by the virus. Therefore, the continuous increase in coronavirus cases across the globe is surging the demand for hydroxychloroquine, generating higher revenues for the market during the period.
Note: Product cover images may vary from those shown
  • Bayer AG
  • Dr. Reddy's Laboratories
  • Zydus Cadila
  • Ipca Laboratories Ltd.
  • Wallace Pharma
  • Teva
  • Mylan
  • Novartis
  • Intas Pharmaceuticals
  • Lupin Limited
  • Shanghai Zhongxisanwei
  • Torrent Pharma
  • BSE healthcare
  • HIKMA
  • Sandoz
  • IPCA Laboratories
  • Cipla Limited
  • Shanghai Pharma
  • Shenhua Pharm
  • Sanofi
  • Macleod Pharmaceuticals
  • H-QYN
  • McW Healthcare
  • Laurus Labs
  • TAJ Pharma
  • Wuhan Wuyao Pharmaceutical
  • MAAN Medex
  • Cinkate
  • Concordia Healthcare
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll